ChanTest Acquires Applied Cell Sciences

10-Mar-2009 - USA

ChanTest announced that it has acquired Applied Cell Sciences. ACS is a contract research organization (CRO) specializing in GPCRs. The combined company will maintain both facilities in Rockville and Cleveland. Jesse Baumgold, Ph.D., who has led ACS since its inception in 2004, has been named ChanTest vice president of business development and product strategy. He will continue to direct the company’s operations in Rockville. Terms of the acquisition were not disclosed.

“We are now uniquely positioned to serve the drug discovery and safety needs of pharmaceutical and biotech customers with the most-comprehensive portfolio available of ion channel and GPCR services, reagents, and cell lines – covering nearly half of the known drugable genome,” said ChanTest President and Chief Executive Officer, Arthur M. “Buzz” Brown, M.D., Ph.D.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics